Ex Vivo Lung Perfusion (EVLP) is a valuable tool for the reassessment of marginal lungs before transplantation and could increase the pool of organs available; the aim of this study was to investigate the characteristics of the recipients of EVLP-assessed grafts and their outcomes in our hospital. A retrospective study was conducted including all lung transplant (LuTx) recipients from January 2011 to December 2015. Two groups of patients were identified based on their graft: EVLP assessed (Group A) or not (Group B). From January 2011 to December 2015, a total of 101 LuTx were performed; of those, 15 grafts underwent EVLP reconditioning. EVLP grafts were given to more severe recipients at time of LuTx, possibly affecting early perioperative results. However the incidence of primary graft dysfunction (PGD) Grade 3 and other medium and long-term outcomes of EVLP were comparable to conventional transplantations. EVLP reconditioning may increase the number of available grafts, also for those patients whose conditions are too severe to wait for another donor.

Five years of EVLP: a monocentric experience / V. Rossetti, L.C. Morlacchi, P. Tarsia, G.M. Ruggeri, L. Rosso, M. Nosotti, F. Blasi, D. Tosi, F. Valenza. ((Intervento presentato al 27. convegno ERS International Congress 2017 / European Respiratory Society’s International Congress tenutosi a Milano nel 2017.

Five years of EVLP: a monocentric experience

L.C. Morlacchi;G.M. Ruggeri;L. Rosso;M. Nosotti;F. Blasi;F. Valenza
2017

Abstract

Ex Vivo Lung Perfusion (EVLP) is a valuable tool for the reassessment of marginal lungs before transplantation and could increase the pool of organs available; the aim of this study was to investigate the characteristics of the recipients of EVLP-assessed grafts and their outcomes in our hospital. A retrospective study was conducted including all lung transplant (LuTx) recipients from January 2011 to December 2015. Two groups of patients were identified based on their graft: EVLP assessed (Group A) or not (Group B). From January 2011 to December 2015, a total of 101 LuTx were performed; of those, 15 grafts underwent EVLP reconditioning. EVLP grafts were given to more severe recipients at time of LuTx, possibly affecting early perioperative results. However the incidence of primary graft dysfunction (PGD) Grade 3 and other medium and long-term outcomes of EVLP were comparable to conventional transplantations. EVLP reconditioning may increase the number of available grafts, also for those patients whose conditions are too severe to wait for another donor.
set-2017
Transplantation; Critically ill patients; Experimental approaches
Settore MED/21 - Chirurgia Toracica
Settore MED/41 - Anestesiologia
Settore MED/10 - Malattie dell'Apparato Respiratorio
Five years of EVLP: a monocentric experience / V. Rossetti, L.C. Morlacchi, P. Tarsia, G.M. Ruggeri, L. Rosso, M. Nosotti, F. Blasi, D. Tosi, F. Valenza. ((Intervento presentato al 27. convegno ERS International Congress 2017 / European Respiratory Society’s International Congress tenutosi a Milano nel 2017.
Conference Object
File in questo prodotto:
File Dimensione Formato  
ERS 2017 (Five years of EVLP...).pdf

accesso aperto

Tipologia: Altro
Dimensione 117 kB
Formato Adobe PDF
117 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/524415
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact